Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
SSE:688621.SS
54.23 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||||||
| Net Income
| 0 | 0 | 59.117 | 75.818 | 72.754 | 13.681 | 53.082 | 70.057 | 47.937 | 27.045 | 41.522 | 53.982 | 33.4 | 20.53 | 26.167 | 39.036 | 21.276 | 22.277 | 11.718 | 23.606 | 16.562 |
| Depreciation & Amortization
| 0 | 0 | 0 | 16.697 | 16.697 | 44.929 | -21.384 | 15.733 | 15.733 | 14.316 | 14.316 | 12.104 | 12.104 | 10.772 | 10.772 | 6.502 | 2.956 | 2.902 | 2.779 | 2.448 | 2.323 |
| Deferred Income Tax
| 0 | 0 | 16.237 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | 0 | 0 | -267.042 | 0 | -252.382 | 167.504 | -167.504 | 0 | -156.618 | 36.007 | -36.007 | 0 | -144.588 | 50.063 | -13.332 | -23.116 | -11.507 | -10.546 | -4.692 | -2.607 |
| Accounts Receivables
| 0 | 0 | 0 | -267.051 | 0 | -250.51 | 166.739 | -166.739 | 0 | -151.922 | 32.517 | -32.517 | 0 | -143.037 | 49.548 | -49.548 | 0 | -35.125 | 3.87 | 4.851 | -8.721 |
| Change In Inventory
| 0 | 0 | 0 | 0.008 | 0 | -1.872 | 0.764 | -0.764 | 0 | -4.696 | 3.491 | -3.491 | 0 | -1.552 | 0.515 | 0.076 | -0.591 | -1.206 | -0.076 | -1.614 | 0.349 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.409 | -22.525 | -10.301 | -10.469 | -3.078 | -2.956 |
| Other Non Cash Items
| 11.029 | 0 | 97.511 | -129.984 | -66.553 | 259.801 | -130.392 | 123.262 | -15.733 | 142.302 | -50.324 | -30.079 | -33.4 | -20.53 | -26.167 | 4.768 | 4.606 | 1.923 | 2.658 | 1.473 | 1.678 |
| Operating Cash Flow
| 11.029 | -73.488 | 172.865 | -70.863 | 6.2 | 66.029 | 68.81 | 41.549 | 47.937 | 27.045 | 41.522 | -0 | -0 | 45.507 | 2.446 | 36.973 | 5.722 | 15.595 | 6.609 | 22.835 | 17.956 |
| Investing Activities: | |||||||||||||||||||||
| Investments In Property Plant And Equipment
| -4.881 | 8.307 | -0.792 | -19.161 | -18.836 | -8.569 | -22.724 | -9.914 | -31.753 | -13.82 | -23.76 | -31.042 | -35.246 | -52.031 | -20.319 | -7.77 | -4.837 | -5.076 | -9.447 | -7.684 | -4.826 |
| Acquisitions Net
| 0 | 0 | 0 | -0.012 | -96 | -30.29 | 7.651 | 0.083 | 0 | 0.309 | 1.438 | 0.003 | 0 | 51.79 | 20.32 | 8.01 | 0.002 | 5.076 | 9.447 | 0 | -3.995 |
| Purchases Of Investments
| -100.049 | -100 | -61 | -20 | -9 | 6 | -7.651 | -0.083 | -26 | -55.75 | -30 | 4 | -4 | -455 | -13 | 53 | -80 | -38.99 | -37.147 | 0 | 0 |
| Sales Maturities Of Investments
| 60.747 | 100 | 20 | 30 | 0.159 | 0.811 | 0.159 | 0.162 | 3.159 | 41.082 | -14.962 | 42.83 | 109.166 | 303.606 | -4.767 | -44.794 | 50.129 | 68.415 | 5.932 | 0 | 0 |
| Other Investing Activites
| 0 | 123.537 | 6.83 | -0.012 | -8.829 | 6.296 | 0.436 | 0.083 | 0 | -0.5 | -1.25 | 0 | -0 | 225.969 | -298.319 | 2.23 | -10 | -5.076 | -9.447 | -2.883 | -4.826 |
| Investing Cash Flow
| -44.184 | 131.844 | -34.962 | -9.173 | -123.665 | -2.273 | -22.129 | -9.669 | -54.594 | -28.679 | -68.534 | 15.791 | 69.921 | 74.334 | -316.084 | 10.675 | -44.707 | 24.349 | -40.662 | -10.567 | -8.821 |
| Financing Activities: | |||||||||||||||||||||
| Debt Repayment
| 167.306 | -45.648 | 20.823 | -114.526 | 151.775 | 67.243 | 0 | 44.879 | 40.74 | -20.745 | -3.588 | 58.5 | 29 | 103.005 | -6.5 | 0 | 0 | 8.5 | -12 | -1.131 | -1.504 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -484.827 | 467.931 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -2.916 | -8.261 | -22.287 | -4.011 | -3.594 | -0.865 | -2.548 | -50.365 | -1.738 | -0.72 | -1.903 | -22.913 | -1.445 | -0.476 | -0.666 | -0.833 | -0.226 | -0.192 | -0.328 | -0.359 | -0.193 |
| Other Financing Activities
| -105.524 | -93.555 | -6.63 | -6.178 | -2.474 | -38.461 | 11.705 | 8.12 | -8.12 | 3.642 | -1.667 | -2.899 | -9.543 | 0.211 | 8.212 | 465.915 | 0.44 | 0 | -1.72 | -0 | 15 |
| Financing Cash Flow
| 58.866 | -147.464 | -8.094 | -124.716 | 145.707 | 27.917 | 16.372 | 2.634 | 30.883 | -17.323 | -7.158 | 32.689 | 18.011 | 101.968 | 0.38 | 465.915 | 0.214 | 8.308 | -14.6 | -1.49 | 13.304 |
| Other Information: | |||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | -0.159 | -0.162 | -131.142 | 68.883 | -71.811 | 34.974 | 3.347 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Net Change In Cash
| 25.014 | -91.645 | 129.809 | -204.753 | 28.243 | 91.672 | 62.894 | 34.351 | -106.916 | 49.926 | -105.981 | 83.454 | 91.279 | 218.969 | -312.815 | 513.563 | -38.771 | 48.252 | -48.653 | 10.778 | 22.438 |
| Cash At End Of Period
| 590.579 | 552.585 | 644.23 | 514.421 | 719.174 | 690.931 | 599.259 | 536.365 | 502.014 | 608.93 | 559.003 | 664.984 | 581.53 | 490.251 | 271.282 | 584.097 | 70.535 | 109.305 | 61.053 | 109.706 | 98.928 |